Click to view a price quote on AGN. : The drugmaker's management and board are "working with multiple advisers with a sense of urgency," Walsh said Tuesday, May 8, at the Deutsche Bank healthcare conference in Boston. The Dublin-based company will provide communications on the review in "weeks, not months," he said. Echoing what CEO Brent Saunders said on Allergan's April 30 earnings call, however, Walsh said a transformational deal "is off the table at the present time." Allergan on April 19 indicated it was considering an offer for Shire plc.